Senard J M, Valet P, Galinier M, Tran M A, Galinier F, Boneu B, Montastruc J L
Laboratoire de pharmacologie médicale et clinique, INSERM U 317, faculté de médecine et CHU, Toulouse.
Arch Mal Coeur Vaiss. 1989 Jul;82(7):1139-41.
The aim of this work was to investigate the influence of blood pressure levels on human platelet alpha 2-adrenergic receptivity. The study was carried out on 12 mild essential hypertensive patients and 7 normotensive parkinsonians with orthostatic hypotension. Alpha 2-adrenoceptors number and affinity were determined by 3H-yohimbine binding, plasma catecholamines were measured by HPLC and adrenaline-induced platelet aggregation by turbidimetry. Results obtained were compared with those of two groups of 12 normotensive control subjects. In hypertensive patients, both platelet alpha 2-adrenoceptors (139 +/- 6 vs 176 +/- 18 fmol/mg protein) and velocity of adrenaline-induced platelet aggregation were decreased whereas plasma adrenaline and noradrenaline remained unchanged. In patients with orthostatic hypotension, there was an increased number of platelet alpha 2-adrenoceptors (313 +/- 52 vs 168 +/- 8 fmol/mg protein) associated with a significant decrease in plasma noradrenaline (62 +/- 11 vs 190 +/- 25 pg/ml). In none of the two groups of patients there was any change in receptor affinity for 3H-yohimbine. These results indicate that human platelet alpha 2-adrenoceptors levels are related to blood pressure values. Moreover, up-regulation in orthostatic hypotension and lack of down-regulation in essential hypertension suggest that only sustained abnormal plasma noradrenaline levels could allow the development of alpha 2-adrenoceptors regulatory mechanisms. These variations can represent tentative compensatory mechanisms for normalization of blood pressure levels.
这项工作的目的是研究血压水平对人体血小板α2 - 肾上腺素能受体反应性的影响。该研究对12例轻度原发性高血压患者和7例患有体位性低血压的血压正常的帕金森病患者进行。通过3H - 育亨宾结合法测定α2 - 肾上腺素能受体的数量和亲和力,采用高效液相色谱法测定血浆儿茶酚胺,并通过比浊法测定肾上腺素诱导的血小板聚集。将所得结果与两组各12名血压正常的对照受试者的结果进行比较。在高血压患者中,血小板α2 - 肾上腺素能受体数量(139±6对176±18 fmol/mg蛋白质)和肾上腺素诱导的血小板聚集速度均降低,而血浆肾上腺素和去甲肾上腺素保持不变。在体位性低血压患者中,血小板α2 - 肾上腺素能受体数量增加(313±52对168±8 fmol/mg蛋白质),同时血浆去甲肾上腺素显著降低(62±11对190±25 pg/ml)。两组患者中,受体对3H - 育亨宾的亲和力均无变化。这些结果表明,人体血小板α2 - 肾上腺素能受体水平与血压值相关。此外,体位性低血压时的上调和原发性高血压时缺乏下调表明,只有持续异常的血浆去甲肾上腺素水平才能使α2 - 肾上腺素能受体调节机制得以发展。这些变化可能代表血压水平正常化的初步代偿机制。